​
Login / Signup
Nan Chen
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 3
Top Topics
Reactive Oxygen Species
Dna Damage
Transcription Factor
Tyrosine Kinase
Top Venues
Thoracic cancer
Cancer research communications
Molecular cancer therapeutics
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Tara L Peters
,
Nan Chen
,
Logan C Tyler
,
Anh T Le
,
Anastasios Dimou
,
Robert C Doebele
Intrinsic resistance to ROS1 inhibition in a patient with CD74-ROS1 mediated by AXL overexpression.
Thoracic cancer
(2023)
Halley M Oyer
,
Alexandra R Steck
,
Charles G Longen
,
Sanjana Venkat
,
Konuralp Bayrak
,
Eleanor B Munger
,
Dan Fu
,
Paola A Castagnino
,
Christina M Sanders
,
Nathalia A Tancler
,
My T Mai
,
Justin P Myers
,
Matthew J Schiewer
,
Nan Chen
,
Elahe A Mostaghel
,
Felix J Kim
Sigma1 Regulates Lipid Droplet Mediated Redox Homeostasis Required for Prostate Cancer Proliferation.
Cancer research communications
(2023)
Nan Chen
,
Logan C Tyler
,
Anh T Le
,
Eric A Welsh
,
Bin Fang
,
Andrew Elliott
,
Kurtis D Davies
,
Laura D Harmacek
,
Gregory J Riely
,
Marc Ladanyi
,
Eric B Haura
,
Robert C Doebele
MIG6 mediates adaptive and acquired resistance to ALK/ROS1 fusion kinase inhibition through EGFR bypass signaling.
Molecular cancer therapeutics
(2023)